The Wroclaw-based biotechnology company has become the first in the world to transport the peptides liraglutide and semaglutide through the skin. The last is a substance used in drugs such as the record-breaking Ozempic and Wegovy from the Danish company NovoNordisk. Transdermally delivered substances belong to the group of glucagon-like peptide-1 (GLP-1) analogs used to […]
Read the full article